3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Spondylitis, Ankylosing
1
Signs and Symptoms
1
Rectal Neoplasms
1
Psoriasis
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lymphedema
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Inflammatory Bowel Diseases
1
Endometrial Neoplasms
1
Crohn Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Colitis, Ulcerative
1
Carcinoma, Renal Cell
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
Bevacizumab
3
durvalumab
2
atezolizumab
2
Hepatectomy
2
tremelimumab
1
trastuzumab deruxtecan
1
pembrolizumab
1
Whole Genome Sequencing
1
Standard of Care
1
Specimen Handling
1
Radionuclide Imaging
1
Platinum
1
Ipilimumab
1
Immunotherapy
1
Immunoglobulin G
1
IMC-001
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Gemcitabine
1
Disulfides
1
Diathermy
1
Cisplatin
1
Cell- and Tissue-Based Therapy
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Methods
×
30 days
×
Clear all
No trials found.